Galmed Pharma (GLMD) IND Cleared by FDA: Submits App for Aramchol Fast Track Designation
Tweet Send to a Friend
Galmed Pharma (Nasdaq: GLMD) announced that the U.S. Food and Drug Administration, or the FDA, cleared Galmed's Investigational New Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
